Skip to main content
Clinical Trials/CTRI/2021/09/036704
CTRI/2021/09/036704
Active, Not Recruiting
Phase 4

Single-blind, randomized study evaluating clinical equivalence of Clinifibre® (Healthium) and FiberWire® (Arthrex) ultra-high-molecular-weight polyethylene (UHMWPE) suture for graft preparation, in patients undergoing arthroscopic unilateral primary Anterior Cruciate Ligament (ACL) Reconstruction

Healthium Medtech Limited0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: M668- Spontaneous rupture of other tendons
Sponsor
Healthium Medtech Limited
Status
Active, Not Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Skeletally mature subjects of both gender aged 18\-50 years undergoing Unilateral Primary ACL Reconstruction
  • 2\. Subjects requiring ultra\-high\-molecular\-weight polyethylene (UHMWPE) suture for hamstring autograft preparation
  • 3\. Subject having contralateral healthy knee on clinical examination
  • 4\. Subject with physical activity classified by Tegner scale \= 1
  • 5\. Subject who has given written informed consent

Exclusion Criteria

  • 1\. Subject with body mass index \<18\.5 or \>30 kg/m2
  • 2\. Subject undergoing ACL reconstruction using bone\-patellar tendon\-bone graft
  • 3\. Subject who is a professional athlete
  • 4\. Subject with HbA1c more than 10
  • 5\. Subject who is a heavy smoker i.e., smoking \= 20 cigarettes per day
  • 6\. Subject having posterior crutiate ligament injury, or other collateral ligament injury
  • 7\. Subject having obvious change in the alignment of the mechanical axis requiring surgical correction (Varus or Valgus malalignment greater than 3 degrees)
  • 8\. Subject having generalized ligamentous laxity (Beighton score of 4 or greater or defined as the simultaneous presence of joint hypermobility at the four limbs and axial skeleton, with involvement of both the major and minor joints)
  • 9\. Subject with history of bleeding disorder, connective tissue disorder or congenital disease that predispose a patient for articular cartilage damage
  • 10\. Subject not achieving 90° of flexion in the affected knee before surgery.

Outcomes

Primary Outcomes

Not specified

Similar Trials